Vector Blog

Thank you for making Boston Children’s #1

The 2017-18 U.S. News & World Report “Best Children’s Hospitals” rankings were released this morning, and Boston Children’s Hospital has been named the #1 children’s hospital in the nation. The U.S. News rankings rely most heavily on outcomes. In other words, were we able to make a difference? At Boston Children’s, that goal is what drives our...

The post Thank you for making Boston Children’s #1 appeared first on Vector.

A new inlet to treating neurological disease

The blood-brain barrier was designed by nature to protect the brain and central nervous system (CNS) from toxins and other would-be invaders in the body’s circulating blood. Made up of tightly-packed cells, the barrier allows nutrients to pass into the CNS and waste products from the brain to be flushed out, while blocking entry of...

The post A new inlet to treating neurological disease appeared first on Vector.

Who We are

The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.

News and Events

TIDO, the Manton Center, and MassBio will co-host a Boston Children’s Rare Disease Networking Event on May 25th from 4:30 – 7:00 pm at MassBio Headquarters in Cambridge. This event will showcase Children’s research in rare diseases and discuss advancing new therapy development through industry-academic collaborations. The program will include an academic-industry panel featuring our CSO David Williams, MD, Manton Center Director Alan Beggs, PhD, Philip Reilly, MD, JD, of Third Rock Ventures, and Alvin Shih, MD, of Enzyvant. In addition, there will be short research talks by Boston Children’s researchers and networking sessions with posters. Register to attend by clicking the above title.

TIDO is proud to announce the release of our new Inventor’s Guide. The booklet details the commercialization process at Boston Children’s, how to work with TIDO to give your invention the best possibility for success, and answers to frequently asked questions we encounter.

The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.

@ChildrensTIDO on Twitter

Connect with us


Terms and Conditions children's hospital
Site Designed and Developed by Genuine